Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes

NCT05193578 is registered in ClinicalTrials.gov with Jan Frystyk as lead sponsor.

NCT NCT05193578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05193578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
Lead sponsor
Jan Frystyk
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2022
Completion date
May 1, 2024
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetic state, schizophrenia